Comparing a vaginal tablet (Misoprostol) and device (Dilapan) kept inside the cervix for dilatation of cervix before operative hysterosocpic procedures
Not Applicable
- Conditions
- Health Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women of age 18 years or more, scheduled for operative hysteroscopic procedures with 26F resectoscope
Exclusion Criteria
Cervical incompetence
Contraindication to Misoprostol use like history of severe asthma, glaucoma, preexisting cardiac disease, hypertension, or renal failure
Significant uterovaginal prolapse precluding the administration of vaginal tablets.
Pelvic inflammatory disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The need for mechanical dilatation, following vaginal Misoprostol or synthetic osmotic dilator (Dilapan) for cervical preparation prior to operative hysteroscopy. <br/ ><br> <br/ ><br>Timepoint: 12 hours after insertion <br/ ><br>
- Secondary Outcome Measures
Name Time Method The side effects and complications of Misoprostol and synthetic osmotic dilator (Dilapan) <br/ ><br> <br/ ><br>Timepoint: 3 weeks